Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Details) - Schedule of stock option activity

v3.23.1
Stockholders' Equity (Details) - Schedule of stock option activity - $ / shares
 12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Feb. 02, 2020
Number of options        
Number of options, outstanding, beginning balance (in shares) 495,366 495,366 495,366  
Number of options, granted (in shares) 0 0 0  
Number of options, canceled and forfeited (in shares) 0 0 0  
Number of options, outstanding, ending balance (in shares) 495,366 495,366 495,366 495,366
Weighted average exercise price        
Weighted average exercise price, outstanding balance (in dollars per share) $ 38.10 $ 38.10 $ 38.10  
Weighted average exercise price, granted (in dollars per share) 0 0 0  
Weighted average exercise price, canceled and forfeited (in dollars per share) 0 0 0  
Weighted average exercise price, outstanding balance (in dollars per share) $ 38.10 $ 38.10 $ 38.10 $ 38.10
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]        
Weighted average remaining contractual life, outstanding (in years) 1 year 4 months 6 days 2 years 4 months 6 days 3 years 4 months 6 days 2 years 4 months 2 days
Average intrinsic value, outstanding, beginning balance (in dollars per share) $ 6,162,000 $ 9,135,000 $ 0  
Average intrinsic value, outstanding, ending balance (in dollars per share) $ 0 $ 6,162,000 $ 9,135,000 $ 0